This Article Full Text Full Text (PDF) Supplementary Data All Versions of this Article: 0008-5472.CAN-09-2006v1 69/20/7953    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Hide, T. Articles by Kondo, T. PubMed PubMed Citation Articles by Hide, T. Articles by Kondo, T. Related Collections Oncogenesis Oncogenesis: In Vitro Preclinical Intervention: In Vitro: Drugs, Mechanisms

Sox11 Prevents Tumorigenesis of Glioma-Initiating Cells by Inducing Neuronal Differentiation

¹ Laboratory for Cell Lineage Modulation, RIKEN Center for Developmental Biology, Kobe, Japan and ² Department of Neurosurgery, Kumamoto University Graduate School of Medical Science, Kumamoto, Japan

Requests for reprints: Toru Kondo, Laboratory for Cell Lineage Modulation, RIKEN Center for Developmental Biology, 2-2-3, Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan. Phone: 81-78-306-3170; Fax: 81-78-306-3171; E-mail: tkondo{at}cdb.riken.jp.

Key Words: Sox11 • glioma-initiating cells • limiting dilution assays • DNA microarray • neuronal differentiation

Recent findings have shown that malignant tumors contain cancer-initiating cells (CIC), which self-renew and are tumorigenic. However, CICs have not been characterized properly due to lack of specific markers. We recently established a mouse glioma cell line, NSCL61, by overexpressing an oncogenic HRas^L61 in p53-deficient neural stem cells. Using limiting dilution assays, we show that only 2 of 24 NSCL61 clones retained their tumorigenicity in vivo, although the others also expressed oncogenic HRas^L61 and could proliferate in culture. A comparison of the gene expression profiles of tumorigenic and nontumorigenic clones showed that the tumorigenic clones had lost Sox11 expression. We show that overexpression of sox11 prevented tumorigenesis of NSCL61s by inducing their neuronal differentiation accompanied with decreased levels of plagl1. We also show that overexpression of plagl1 abolished neuronal commitment of nontumorigenic cells and induced them to become tumorigenic. Moreover, we show that human glioma-initiating cells lost sox11 expression, and overexpression of sox11 prevented their tumorigenesis in vivo. Together with the clinical evidence showing that downregulation of sox11 mRNA correlates with a significant decrease in survival, these findings suggest that Sox11 prevents gliomagenesis by blocking the expression of oncogenic plagl1. [Cancer Res 2009;69(20):7953–9]